HK1040239A1 - Process for preparing N6-substituted deaza-adenosine derivatives. - Google Patents

Process for preparing N6-substituted deaza-adenosine derivatives.

Info

Publication number
HK1040239A1
HK1040239A1 HK01107707A HK01107707A HK1040239A1 HK 1040239 A1 HK1040239 A1 HK 1040239A1 HK 01107707 A HK01107707 A HK 01107707A HK 01107707 A HK01107707 A HK 01107707A HK 1040239 A1 HK1040239 A1 HK 1040239A1
Authority
HK
Hong Kong
Prior art keywords
preparing
adenosine derivatives
substituted
deaza
substituted deaza
Prior art date
Application number
HK01107707A
Other languages
English (en)
Inventor
Adam W Sledeski
Luc Grondard
Matthew R Powers
Tory H Powner
Michael K O'brien
Ching T Tsuei
Patrick Leon
Gregory G Kubiak
Laurence Pailleres-Hubert
Benoit Viguier
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1040239A1 publication Critical patent/HK1040239A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK01107707A 1998-12-31 2001-11-05 Process for preparing N6-substituted deaza-adenosine derivatives. HK1040239A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11448698P 1998-12-31 1998-12-31
US11602899P 1999-01-15 1999-01-15
PCT/US1999/029841 WO2000040584A2 (en) 1998-12-31 1999-12-15 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
HK1040239A1 true HK1040239A1 (en) 2002-05-31

Family

ID=26812247

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107707A HK1040239A1 (en) 1998-12-31 2001-11-05 Process for preparing N6-substituted deaza-adenosine derivatives.

Country Status (16)

Country Link
US (1) US6429315B1 (xx)
EP (1) EP1140933B1 (xx)
JP (1) JP2002534430A (xx)
KR (1) KR20010089751A (xx)
CN (1) CN1383427A (xx)
AT (1) ATE275565T1 (xx)
AU (1) AU2187100A (xx)
BR (1) BR9917000A (xx)
CA (1) CA2358962A1 (xx)
DE (1) DE69920045T2 (xx)
DK (1) DK1140933T3 (xx)
ES (1) ES2228163T3 (xx)
HK (1) HK1040239A1 (xx)
PT (1) PT1140933E (xx)
SI (1) SI1140933T1 (xx)
WO (1) WO2000040584A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1140933T3 (da) 1998-12-31 2004-12-20 Aventis Pharma Inc Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
KR20080110925A (ko) 2006-04-21 2008-12-19 노파르티스 아게 아데노신 ａ２ａ 수용체 효능제로서 사용하기 위한 퓨린 유도체
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
BRPI0718792A2 (pt) * 2006-11-10 2013-12-03 Novartis Ag Compostos orgânicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
ES2095960T3 (es) 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
US5545769A (en) 1994-09-29 1996-08-13 E. I. Du Pont De Nemours And Company Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein
US5684159A (en) 1995-05-30 1997-11-04 Rhone-Poulenc Rorer S.A. L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds
FR2734822B1 (fr) 1995-05-30 1997-07-04 Rhone Poulenc Rorer Sa Nouveaux derives du 2-azabicyclo(2.2.1)heptane, leur preparation et leur application
CZ203998A3 (cs) 1996-01-02 1999-11-17 Rhone-Poulenc Rorer Pharmaceuticals Inc. Způsob přípravy 2,4-dihydroxypyridinu a 2,4-dihydroxy-3-nitropyridinu
UA51716C2 (uk) * 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
SK26999A3 (en) 1996-09-12 1999-10-08 Rhone Poulenc Rorer Pharma Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2- -substituted ethyl-2-amines
MXPA03006730A (es) 1996-12-11 2003-10-24 Aventis Pharma Inc Preparacion de 4-hidroxi-3-nitro-2(1h)-piridona.
DK1140933T3 (da) 1998-12-31 2004-12-20 Aventis Pharma Inc Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater

Also Published As

Publication number Publication date
SI1140933T1 (en) 2005-02-28
BR9917000A (pt) 2001-12-11
CN1383427A (zh) 2002-12-04
WO2000040584A3 (en) 2000-11-02
ES2228163T3 (es) 2005-04-01
EP1140933B1 (en) 2004-09-08
KR20010089751A (ko) 2001-10-08
US6429315B1 (en) 2002-08-06
CA2358962A1 (en) 2000-07-13
DE69920045D1 (de) 2004-10-14
PT1140933E (pt) 2004-12-31
JP2002534430A (ja) 2002-10-15
ATE275565T1 (de) 2004-09-15
WO2000040584A2 (en) 2000-07-13
DE69920045T2 (de) 2005-09-29
AU2187100A (en) 2000-07-24
DK1140933T3 (da) 2004-12-20
EP1140933A2 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
AU2489197A (en) Carbocyclic intermediates and process of manufacture thereof
MX9707706A (es) Compuestos intermediarios novedosos y proceso para la manufactura de derivados de la camptotecina (cpt-11) y compuestos relacionados.
HK1040239A1 (en) Process for preparing N6-substituted deaza-adenosine derivatives.
CY2522B1 (en) 2-Substituted nucleosides and oligonucleotide derivatives
IL134468A0 (en) 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
HU9700886D0 (en) New intermediates and process for producing them
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
JO2252B1 (en) Method for preparing pyridine derivatives
HK1034512A1 (en) Process for the production of purine derivatives and intermediates therefor
YU51401A (sh) Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima
HUP0003203A2 (hu) Eljárás bisz-indolil-maleimidek előállítására
AU4498799A (en) Method of preparing 5- or 8-bromoisoquinoline derivatives
HK1051558A1 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives.
IL143079A0 (en) Process for the production of cyclene
PL338215A1 (en) Method of obtaining 3-cyano-2,4-dichlorogeno-5-fluorobenzoic acids
AU5497396A (en) Process for the synthesis of nucleoside analogues
PL323908A1 (en) Method of synthesising benzo[b]thiophenes
PL323909A1 (en) Method of producing benzo[b]thiophenes
AU6584601A (en) Method for producing indols
HRP20020021B1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
IL146257A0 (en) Method of producing methoxyimido acetic amide
MX9601818A (es) Conversion de 8-cloroquinolinas sustituidas a 8-hidroxiquinolinas sustituidas.
MX9709129A (es) Proceso para la sintesis de benzo[b]tiofenos.
MX9709672A (es) Proceso para la sintesis de benzo[b]tiofenos.

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081215